S Biomedics Co (XKRX:304360) Common Stock : ₩5,700 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co Common Stock?

S Biomedics Co's quarterly common stock declined from Sep. 2023 (₩5,699 Mil) to Dec. 2023 (₩5,669 Mil) but then increased from Dec. 2023 (₩5,669 Mil) to Mar. 2024 (₩5,700 Mil).

S Biomedics Co's annual common stock increased from Dec. 2020 (₩5,075 Mil) to Dec. 2021 (₩5,110 Mil) but then stayed the same from Dec. 2021 (₩5,110 Mil) to Dec. 2022 (₩5,110 Mil).

S Biomedics Co Common Stock Historical Data

The historical data trend for S Biomedics Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co Common Stock Chart

S Biomedics Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Common Stock

Get a 7-Day Free Trial

1,191.34

1,251.22

5,074.89

5,109.89

S Biomedics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															5,109.89	5,647.54	5,698.54	5,668.54	5,699.54

S Biomedics Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

S Biomedics Co (XKRX:304360) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797

Website

https://www.sbiomedics.com

S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines